-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ayala Pharmaceuticals, Inc. annual/quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2023.
- Ayala Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 4.78M shares, a 64.9% increase year-over-year.
- Ayala Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.02M shares, a 108% increase from 2022.
- Ayala Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 2.9M shares.
- Ayala Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2011 was 223M shares, a 47.7% increase from 2010.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)